KemPharm Shares Outstanding 2014-2019 | KMPH

KemPharm shares outstanding from 2014 to 2019. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
KemPharm Annual Shares Outstanding
(Millions of Shares)
2018 18
2017 15
2016 15
2015 7
2014 2
2013 2
KemPharm Quarterly Shares Outstanding
(Millions of Shares)
Q1 2019 27
Q4 2018 18
Q3 2018 16
Q2 2018 17
Q1 2018 15
Q4 2017 15
Q3 2017 15
Q2 2017 15
Q1 2017 15
Q4 2016 15
Q3 2016 15
Q2 2016 15
Q1 2016 14
Q4 2015 7
Q3 2015 14
Q2 2015 12
Q1 2015 2
Q4 2014 2
Q3 2014 2
Q2 2014 2
Q1 2014 2
Q4 2013 0
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.038B $0.000B
KemPharm Inc. is a specialty pharmaceutical company which is engaged in the discovery and development of new molecular entity prodrugs. Its product candidates include KP201/APAP, KP511/ER and KP606/ER for the treatment of pain; KP415 for the treatment of attention deficit hyperactivity disorder and KP303 for the treatment of central nervous system disorders, which are in preclinical trail stage. The Company through its LAT platform technology generate prodrug. KemPharm Inc. is based in CORALVILLE, United States.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $48.809B 31.18
Takeda Pharmaceutical (TAK) Japan $27.294B 10.10
Grifols (GRFS) Spain $12.617B 15.96
Ionis Pharmaceuticals (IONS) United States $9.458B 20.67
Sage Therapeutics (SAGE) United States $8.591B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.885B 10.80
Neurocrine Biosciences (NBIX) United States $7.214B 0.00
Catalent (CTLT) United States $6.611B 26.53
Nektar Therapeutics (NKTR) United States $5.581B 9.10
Tilray (TLRY) Canada $4.419B 0.00
United Therapeutics (UTHR) United States $3.971B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.964B 12.76
FibroGen (FGEN) United States $3.082B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.560B 9.22
PTC Therapeutics (PTCT) United States $2.275B 0.00
Portola Pharmaceuticals (PTLA) United States $2.013B 0.00
Xencor (XNCR) United States $1.931B 52.72
Arrowhead Pharmaceuticals (ARWR) United States $1.845B 278.00
Pacira Pharmaceuticals (PCRX) United States $1.806B 87.46
Aerie Pharmaceuticals (AERI) United States $1.794B 0.00
Tricida (TCDA) United States $1.772B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.771B 24.20
USANA Health Sciences (USNA) United States $1.763B 15.32
Ironwood Pharmaceuticals (IRWD) United States $1.741B 0.00
Madrigal Pharmaceuticals (MDGL) United States $1.590B 0.00
Zogenix (ZGNX) United States $1.587B 0.00
Endo (ENDP) Ireland $1.475B 2.37
Heron Therapeutics (HRTX) United States $1.430B 0.00
Esperion Therapeutics (ESPR) United States $1.392B 0.00
Corcept Therapeutics (CORT) United States $1.247B 17.80
Theravance Biopharma (TBPH) Cayman Islands $1.158B 0.00
TURNING PT THER (TPTX) United States $1.016B 0.00
Radius Health (RDUS) United States $0.971B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.924B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.809B 0.00
TherapeuticsMD (TXMD) United States $0.803B 0.00
ArQule (ARQL) United States $0.741B 0.00
ChemoCentryx (CCXI) United States $0.722B 0.00
Aptorum Group (APM) China $0.716B 0.00
Akebia Therapeutics (AKBA) United States $0.648B 0.00
ORGANOGENESIS (ORGO) United States $0.636B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.632B 0.00
CannTrust Holdings (CTST) Canada $0.632B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.604B 0.00
Odonate Therapeutics (ODT) United States $0.597B 0.00
Dermira (DERM) United States $0.564B 0.00
GlycoMimetics (GLYC) United States $0.535B 0.00
Translate Bio (TBIO) United States $0.510B 0.00
Flexion Therapeutics (FLXN) United States $0.476B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.468B 23.65
Corbus Pharmaceuticals Holdings (CRBP) United States $0.456B 0.00
Siga Technologies (SIGA) United States $0.452B 1.06
Collegium Pharmaceutical (COLL) United States $0.418B 0.00
Mast Therapeutics (SVRA) United States $0.411B 0.00
KalVista Pharmaceuticals (KALV) United States $0.410B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.390B 0.00
OptiNose (OPTN) United States $0.378B 0.00
Forty Seven (FTSV) United States $0.378B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.359B 0.00
TCR2 Therapeutics (TCRR) United States $0.337B 0.00
Xeris Pharmaceuticals (XERS) United States $0.334B 0.00
ImmunoGen (IMGN) United States $0.307B 0.00
Dova Pharmaceuticals (DOVA) United States $0.304B 0.00
CASI Pharmaceuticals (CASI) United States $0.302B 0.00
Karyopharm Therapeutics (KPTI) United States $0.282B 0.00
Harpoon Therapeutics (HARP) United States $0.279B 0.00
Molecular Templates (MTEM) United States $0.275B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.261B 0.00
Concert Pharmaceuticals (CNCE) United States $0.252B 0.00
Aratana Therapeutics (PETX) United States $0.239B 0.00
MEI Pharma (MEIP) United States $0.237B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.237B 0.00
Lannett Co Inc (LCI) United States $0.236B 2.29
Aclaris Therapeutics (ACRS) United States $0.233B 0.00
Minerva Neurosciences (NERV) United States $0.231B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.229B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.226B 0.00
Calithera Biosciences (CALA) United States $0.221B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.221B 0.00
Galectin Therapeutics (GALT) United States $0.207B 0.00
Aldeyra Therapeutics (ALDX) United States $0.201B 0.00
Recro Pharma (REPH) United States $0.199B 0.00
Opexa Therapeutics (ACER) United States $0.193B 0.00
IMV INC (IMV) Canada $0.191B 0.00
Majesco Entertainment (PTE) United States $0.189B 0.00
Ardelyx (ARDX) United States $0.187B 0.00
Nature's Sunshine Products (NATR) United States $0.182B 59.06
Taiwan Liposome, Unsponsored ADR (TLC) Taiwan $0.169B 0.00
Redhill Biopharma (RDHL) Israel $0.168B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.166B 0.00
Jounce Therapeutics (JNCE) United States $0.161B 0.00
Tyme Technologies (TYME) United States $0.152B 0.00
Ocular Therapeutix (OCUL) United States $0.148B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.148B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.145B 0.00
Neon Therapeutics (NTGN) United States $0.144B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.135B 0.00
Aquestive Therapeutics (AQST) United States $0.126B 0.00
Bio Blast Pharma (ENLV) Israel $0.124B 0.00
DURECT (DRRX) United States $0.121B 0.00
MediWound (MDWD) Israel $0.121B 0.00
Nivalis Therapeutics (ALPN) United States $0.111B 0.00
ProNAi Therapeutics (SRRA) Canada $0.109B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.101B 72.22
Cardiome Pharma (CORV) Canada $0.100B 0.00
Iterum Therapeutics (ITRM) Ireland $0.099B 0.00
Champions Oncology (CSBR) United States $0.099B 0.00
China SXT Pharmaceuticals (SXTC) China $0.099B 0.00
Natural Alternatives (NAII) United States $0.097B 9.67
Zafgen (ZFGN) United States $0.093B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.090B 0.00
ElectroCore (ECOR) United States $0.089B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.087B 0.00
Otonomy (OTIC) United States $0.086B 0.00
Neos Therapeutics (NEOS) United States $0.085B 0.00
Infinity Pharmaceuticals (INFI) United States $0.084B 0.00
Adherex Technologies (FENC) United States $0.081B 0.00
Genocea Biosciences (GNCA) United States $0.078B 0.00
Avenue Therapeutics (ATXI) United States $0.078B 0.00
SCYNEXIS (SCYX) United States $0.077B 0.00
Capnia (SLNO) United States $0.062B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.050B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.049B 0.00
AIT Therapeutics (AITB) Israel $0.047B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.047B 0.00
CTI BioPharma (CTIC) United States $0.046B 0.00
Lipocine (LPCN) United States $0.046B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.045B 0.00
Forward Pharma (FWP) Denmark $0.045B 0.00
Bio-Path Holdings (BPTH) United States $0.044B 0.00
Novan (NOVN) United States $0.044B 0.00
Mannatechorporated (MTEX) United States $0.041B 0.00
BioLineRx (BLRX) Israel $0.041B 0.00
ContraFect (CFRX) United States $0.039B 0.00
Melinta Therapeutics (MLNT) United States $0.036B 0.00
ProPhase Labs (PRPH) United States $0.035B 0.00
Citius Pharmaceuticals (CTXR) United States $0.030B 0.00
Heat Biologics (HTBX) United States $0.029B 0.00
HANCOCK JAFFE (HJLI) United States $0.027B 0.00
Achieve Life Sciences (ACHV) United States $0.024B 0.00
Regulus Therapeutics (RGLS) United States $0.024B 0.00
Biomerica (BMRA) United States $0.023B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.022B 2.93
PharmAthene (ALT) United States $0.022B 0.00
Onconova Therapeutics (ONTX) United States $0.022B 0.00
Jaguar Animal Health (JAGX) United States $0.021B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.020B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.020B 0.00
Pain Therapeutics (SAVA) United States $0.019B 0.00
Cyanotech (CYAN) United States $0.019B 0.00
Shineco (TYHT) China $0.019B 3.11
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.016B 0.00
ESSA Pharma (EPIX) Canada $0.014B 0.00
Trillium Therapeutics (TRIL) Canada $0.013B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.012B 3.97
VAXART, INC (VXRT) United States $0.012B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.011B 0.00
RXi Pharmaceuticals (PHIO) United States $0.011B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.010B 0.00
PRECISION THERAPEUTICS INC (AIPT) United States $0.010B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.010B 0.00
Xenetic Biosciences (XBIO) United States $0.008B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.008B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.007B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.006B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.006B 0.00
Midatech Pharma (MTP) United Kingdom $0.005B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00